Intersectin 1 (ITSN1) is an evolutionarily conserved adaptor protein that functions in clathrin-mediated endocytosis, cell signalling and cytoskeleton rearrangements. The ITSN1 gene encodes two main isoforms: a short form (ITSN1-s), which is ubiquitously expressed and consists of two Eps15 homology (EH) domains and five Src homology 3 (SH3) domains, and a long form (ITSN1-l), which is predominantly expressed in the brain and contains three additional domains, a Dbl homology (DH) domain, a Pleckstrin homology (PH) domain and a C2 domain. Using computational analysis of the EST database and 3' RACE we determined the length of the 3' untranslated region of ITSN1-l and demonstrated that the polyadenylation site is located 11,559 nt downstream of the stop codon of the ITSN1-l mRNA. Recently, additional splicing events affecting ITSN1 transcripts were reported, but full-length transcriptional isoforms with different combinations of alternatively spliced exons remained unknown. Here we report the identification of fifteen novel transcriptional isoforms of the human ITSN1 gene with full-length coding sequences that are the result of different combinations of the alternatively spliced exons 5, 6/6', 20, 23, 25, 26, 26a and 35. The isoforms identified differ in domain organization and expression level in different tissues and more likely contribute to the modulation of many complex protein interactions in which ITSN1 participates.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11033-009-9824-8DOI Listing

Publication Analysis

Top Keywords

itsn1 gene
8
homology domain
8
transcriptional isoforms
8
combinations alternatively
8
alternatively spliced
8
spliced exons
8
isoforms
5
itsn1
5
structural diversity
4
diversity differential
4

Similar Publications

Article Synopsis
  • Around 40% of older adults (65+) face memory loss, particularly in episodic memory, raising the need to explore its genetic reasons.* -
  • A study of 742 Ashkenazi Jewish individuals revealed links between episodic memory decline and rare genetic variants in the ITSN1 and CRHR2 genes, alongside common Alzheimer's polygenic risk.* -
  • The findings suggest that different memory-related issues can arise from rare variants, highlighting new genetic risk factors and the need to understand the biological processes behind them.*
View Article and Find Full Text PDF
Article Synopsis
  • - Parkinson's disease (PD) is a serious neurodegenerative disorder, and rising cases emphasize the need to identify factors that can be changed to reduce risk.
  • - A study involving 8,647 PD patients and 777,693 controls identified a new link between rare ITSN1 gene variants and PD, supported by other research databases.
  • - The research suggests that issues with Rho GTPases and synaptic vesicle transport might play a role in PD development, indicating potential new treatment strategies.
View Article and Find Full Text PDF

Alzheimer's disease (AD) is the most common form of dementia and is characterized by the accumulation of amyloid-beta (Aβ) plaques and neurofibrillary Tau tangles in the brain. We previously identified a set of candidate AD microRNAs (miRNAs) in human cerebrospinal fluid (CSF) and used a target prediction pipeline to identify mRNAs and pathways that could potentially be regulated by the miRNAs. Of these pathways, clathrin mediated endocytosis (CME) was selected for further investigation.

View Article and Find Full Text PDF

Objective: Long noncoding RNAs (lncRNAs) play an increasingly important role in various autoimmune diseases. We aimed to characterize the expression profiles of lncRNAs in peripheral blood mononuclear cells (PBMCs) from RA patients and to assess the potential of these lncRNAs as RA biomarkers.

Methods: Whole-transcriptome sequencing was used to establish a lncRNA expression profile.

View Article and Find Full Text PDF

Down syndrome (DS) is the most common form of inherited intellectual disability caused by trisomy of chromosome 21, presenting with intellectual impairment, craniofacial abnormalities, cardiac defects, and gastrointestinal disorders. The Ts65Dn mouse model replicates many abnormalities of DS. We hypothesized that investigation of the cerebral cortex of fluoxetine-treated trisomic mice may provide proteomic signatures that identify therapeutic targets for DS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!